The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical 3D Bioprinting Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 SLA
1.2.3 FDM
1.2.4 LOM
1.2.5 Others
1.3 Market by Application
1.3.1 Global Medical 3D Bioprinting Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical Device Manufacturers
1.3.3 Pharmaceutical Companies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medical 3D Bioprinting Market Perspective (2018-2029)
2.2 Medical 3D Bioprinting Growth Trends by Region
2.2.1 Global Medical 3D Bioprinting Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medical 3D Bioprinting Historic Market Size by Region (2018-2023)
2.2.3 Medical 3D Bioprinting Forecasted Market Size by Region (2024-2029)
2.3 Medical 3D Bioprinting Market Dynamics
2.3.1 Medical 3D Bioprinting Industry Trends
2.3.2 Medical 3D Bioprinting Market Drivers
2.3.3 Medical 3D Bioprinting Market Challenges
2.3.4 Medical 3D Bioprinting Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical 3D Bioprinting Players by Revenue
3.1.1 Global Top Medical 3D Bioprinting Players by Revenue (2018-2023)
3.1.2 Global Medical 3D Bioprinting Revenue Market Share by Players (2018-2023)
3.2 Global Medical 3D Bioprinting Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical 3D Bioprinting Revenue
3.4 Global Medical 3D Bioprinting Market Concentration Ratio
3.4.1 Global Medical 3D Bioprinting Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical 3D Bioprinting Revenue in 2022
3.5 Medical 3D Bioprinting Key Players Head office and Area Served
3.6 Key Players Medical 3D Bioprinting Product Solution and Service
3.7 Date of Enter into Medical 3D Bioprinting Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical 3D Bioprinting Breakdown Data by Type
4.1 Global Medical 3D Bioprinting Historic Market Size by Type (2018-2023)
4.2 Global Medical 3D Bioprinting Forecasted Market Size by Type (2024-2029)
5 Medical 3D Bioprinting Breakdown Data by Application
5.1 Global Medical 3D Bioprinting Historic Market Size by Application (2018-2023)
5.2 Global Medical 3D Bioprinting Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medical 3D Bioprinting Market Size (2018-2029)
6.2 North America Medical 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medical 3D Bioprinting Market Size by Country (2018-2023)
6.4 North America Medical 3D Bioprinting Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medical 3D Bioprinting Market Size (2018-2029)
7.2 Europe Medical 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medical 3D Bioprinting Market Size by Country (2018-2023)
7.4 Europe Medical 3D Bioprinting Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical 3D Bioprinting Market Size (2018-2029)
8.2 Asia-Pacific Medical 3D Bioprinting Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medical 3D Bioprinting Market Size by Region (2018-2023)
8.4 Asia-Pacific Medical 3D Bioprinting Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medical 3D Bioprinting Market Size (2018-2029)
9.2 Latin America Medical 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medical 3D Bioprinting Market Size by Country (2018-2023)
9.4 Latin America Medical 3D Bioprinting Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical 3D Bioprinting Market Size (2018-2029)
10.2 Middle East & Africa Medical 3D Bioprinting Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medical 3D Bioprinting Market Size by Country (2018-2023)
10.4 Middle East & Africa Medical 3D Bioprinting Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3D Systems
11.1.1 3D Systems Company Detail
11.1.2 3D Systems Business Overview
11.1.3 3D Systems Medical 3D Bioprinting Introduction
11.1.4 3D Systems Revenue in Medical 3D Bioprinting Business (2018-2023)
11.1.5 3D Systems Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Detail
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Medical 3D Bioprinting Introduction
11.2.4 GE Healthcare Revenue in Medical 3D Bioprinting Business (2018-2023)
11.2.5 GE Healthcare Recent Development
11.3 ExOne
11.3.1 ExOne Company Detail
11.3.2 ExOne Business Overview
11.3.3 ExOne Medical 3D Bioprinting Introduction
11.3.4 ExOne Revenue in Medical 3D Bioprinting Business (2018-2023)
11.3.5 ExOne Recent Development
11.4 Electro Optical Systems
11.4.1 Electro Optical Systems Company Detail
11.4.2 Electro Optical Systems Business Overview
11.4.3 Electro Optical Systems Medical 3D Bioprinting Introduction
11.4.4 Electro Optical Systems Revenue in Medical 3D Bioprinting Business (2018-2023)
11.4.5 Electro Optical Systems Recent Development
11.5 Renishaw
11.5.1 Renishaw Company Detail
11.5.2 Renishaw Business Overview
11.5.3 Renishaw Medical 3D Bioprinting Introduction
11.5.4 Renishaw Revenue in Medical 3D Bioprinting Business (2018-2023)
11.5.5 Renishaw Recent Development
11.6 Stratasys
11.6.1 Stratasys Company Detail
11.6.2 Stratasys Business Overview
11.6.3 Stratasys Medical 3D Bioprinting Introduction
11.6.4 Stratasys Revenue in Medical 3D Bioprinting Business (2018-2023)
11.6.5 Stratasys Recent Development
11.7 EnvisionTEC
11.7.1 EnvisionTEC Company Detail
11.7.2 EnvisionTEC Business Overview
11.7.3 EnvisionTEC Medical 3D Bioprinting Introduction
11.7.4 EnvisionTEC Revenue in Medical 3D Bioprinting Business (2018-2023)
11.7.5 EnvisionTEC Recent Development
11.8 Cyfuse Biomedical
11.8.1 Cyfuse Biomedical Company Detail
11.8.2 Cyfuse Biomedical Business Overview
11.8.3 Cyfuse Biomedical Medical 3D Bioprinting Introduction
11.8.4 Cyfuse Biomedical Revenue in Medical 3D Bioprinting Business (2018-2023)
11.8.5 Cyfuse Biomedical Recent Development
11.9 Formlabs
11.9.1 Formlabs Company Detail
11.9.2 Formlabs Business Overview
11.9.3 Formlabs Medical 3D Bioprinting Introduction
11.9.4 Formlabs Revenue in Medical 3D Bioprinting Business (2018-2023)
11.9.5 Formlabs Recent Development
11.10 Organovo Holdings
11.10.1 Organovo Holdings Company Detail
11.10.2 Organovo Holdings Business Overview
11.10.3 Organovo Holdings Medical 3D Bioprinting Introduction
11.10.4 Organovo Holdings Revenue in Medical 3D Bioprinting Business (2018-2023)
11.10.5 Organovo Holdings Recent Development
11.11 Allevi
11.11.1 Allevi Company Detail
11.11.2 Allevi Business Overview
11.11.3 Allevi Medical 3D Bioprinting Introduction
11.11.4 Allevi Revenue in Medical 3D Bioprinting Business (2018-2023)
11.11.5 Allevi Recent Development
11.12 Advanced Solutions
11.12.1 Advanced Solutions Company Detail
11.12.2 Advanced Solutions Business Overview
11.12.3 Advanced Solutions Medical 3D Bioprinting Introduction
11.12.4 Advanced Solutions Revenue in Medical 3D Bioprinting Business (2018-2023)
11.12.5 Advanced Solutions Recent Development
11.13 Aspect Biosystems
11.13.1 Aspect Biosystems Company Detail
11.13.2 Aspect Biosystems Business Overview
11.13.3 Aspect Biosystems Medical 3D Bioprinting Introduction
11.13.4 Aspect Biosystems Revenue in Medical 3D Bioprinting Business (2018-2023)
11.13.5 Aspect Biosystems Recent Development
11.14 CELLINK
11.14.1 CELLINK Company Detail
11.14.2 CELLINK Business Overview
11.14.3 CELLINK Medical 3D Bioprinting Introduction
11.14.4 CELLINK Revenue in Medical 3D Bioprinting Business (2018-2023)
11.14.5 CELLINK Recent Development
11.15 GeSiM
11.15.1 GeSiM Company Detail
11.15.2 GeSiM Business Overview
11.15.3 GeSiM Medical 3D Bioprinting Introduction
11.15.4 GeSiM Revenue in Medical 3D Bioprinting Business (2018-2023)
11.15.5 GeSiM Recent Development
11.16 Bio3D Technologies
11.16.1 Bio3D Technologies Company Detail
11.16.2 Bio3D Technologies Business Overview
11.16.3 Bio3D Technologies Medical 3D Bioprinting Introduction
11.16.4 Bio3D Technologies Revenue in Medical 3D Bioprinting Business (2018-2023)
11.16.5 Bio3D Technologies Recent Development
11.17 Regenovo Biotechnology
11.17.1 Regenovo Biotechnology Company Detail
11.17.2 Regenovo Biotechnology Business Overview
11.17.3 Regenovo Biotechnology Medical 3D Bioprinting Introduction
11.17.4 Regenovo Biotechnology Revenue in Medical 3D Bioprinting Business (2018-2023)
11.17.5 Regenovo Biotechnology Recent Development
11.18 Optomec
11.18.1 Optomec Company Detail
11.18.2 Optomec Business Overview
11.18.3 Optomec Medical 3D Bioprinting Introduction
11.18.4 Optomec Revenue in Medical 3D Bioprinting Business (2018-2023)
11.18.5 Optomec Recent Development
11.19 Mecuris
11.19.1 Mecuris Company Detail
11.19.2 Mecuris Business Overview
11.19.3 Mecuris Medical 3D Bioprinting Introduction
11.19.4 Mecuris Revenue in Medical 3D Bioprinting Business (2018-2023)
11.19.5 Mecuris Recent Development
11.20 Fluicell
11.20.1 Fluicell Company Detail
11.20.2 Fluicell Business Overview
11.20.3 Fluicell Medical 3D Bioprinting Introduction
11.20.4 Fluicell Revenue in Medical 3D Bioprinting Business (2018-2023)
11.20.5 Fluicell Recent Development
11.21 BigRep
11.21.1 BigRep Company Detail
11.21.2 BigRep Business Overview
11.21.3 BigRep Medical 3D Bioprinting Introduction
11.21.4 BigRep Revenue in Medical 3D Bioprinting Business (2018-2023)
11.21.5 BigRep Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details